A Phase 3 interventional study of Colgate Cavity Protection and TOM's Superior Sensitivity Relief Toothpaste in Plaque, Dental, sponsored by Colgate Palmolive. Completed at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-05-02.
Sponsored by Colgate Palmolive · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 34 studies in Dental Plaque by Colgate Palmolive — 2 open to participants now, 3 under way, 3 of them phase 3. Dental Plaque · Colgate Palmolive.
Among the 34 studies in Dental Plaque by Colgate Palmolive, this one is the 29th largest by enrollment, is one of 8 that started in 2024, is one of 26 in phase 3, and was the 29th registered.
353 studies on the registry are indexed under Dental Plaque; 60 are open to participants now.
Browse Dental Plaque studies →2 of the 34 studies in Dental Plaque by Colgate Palmolive are open now, in 2 countries. Recruiting first, the newest first:
Colgate Palmolive · Sites in Italy
Ages 18–70 · Healthy volunteers
Colgate Palmolive · Sites in China
Ages 18–70 · Healthy volunteers
By country, each count listing its studies:
Of the 35 Dental Plaque studies recruiting now, 10 (29%) set no upper age limit and 20 (57%) stop at 75 or younger; 14 take children under 18; 22 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
34 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 8 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 20 is below the median of 55 across 317 interventional studies indexed under Dental Plaque.
Median enrollment 85 across the 34 interventional studies. Of the 31 that completed or were terminated, 15 (48%) have results posted.
This tab as a report to print or save as PDF → With an account.
Colgate Palmolive is the lead sponsor of 120 studies on the registry; 14 are open to participants now.
Of its 36 completed or terminated interventional studies of FDA-regulated products, 2 (6%) have results posted.
2 of the studies in Dental Plaque by Colgate Palmolive that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07605338Phase 3Colgate PalmoliveTo Assess the Efficacy of Two Brushing Regimens: in the Reduction of Established Dental Plaque and Gingivitis. | 2026-11 |
| NCT07842991Phase 3Colgate PalmoliveClinical Evaluation of a Toothpaste for Dental Plaque Reduction and Prevention of Gum Problems | 2027-01 |
Add all 2 to your calendar (.ics) → With an account.
Among the 34 studies in Dental Plaque by Colgate Palmolive, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Proof of concept clinical study to measure plaque metabolism and the prebiotic efficacy of arginine-containing toothpaste.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
fluoride toothpaste
Drug: Colgate Cavity Protection
non fluoride toothpaste
Drug: TOM's Superior Sensitivity Relief Toothpaste
1000ppm fluoride
fluoride free
Plaque collection
Fasting plaque will be collected before and after a sucrose rinse for lactic acid analysis and ammonia production.The plaque pH of collected samples will also be measured to provide trend data.
Time frame: baseline, week 3, week 4, week 6, week 7, week 8, week 9
Saliva collection
Differences in the arginine concentration in saliva pre- and post-brushing with treatment. Differences in microbiome composition and activity
Time frame: week 5 and week 9
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2024 to primary completion in Sep 2024, 1 month.
Of 20 phase 3 interventional studies under Dental Plaque, half reached primary completion within 2 months of starting (the median), counting those still running; a quarter within 1 and three quarters within 4. This study's 1 month is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.